Venture Perspectives By Scale Venture Partners

It’s August 2009 and in the last 12 months, Lou Bock‘s portfolio has had some impressive success. He talks about how Zogenix, Horizon Therapeutics, Somaxon, Prestwick Pharmaceuticals and Orexigen have all done well. The Scale Venture [See the full post…] Related Posts:Enterprise IT Solutions with Hitachi Data Systems – Intel Chip Chat – Episode 447Intel AIPG: Driving AI Innovation – Intel Chip Chat – Episode 543Tech Tonics: Darshak Sanghavi, Public Health PediatricianInnovating for Operators – Intel Chip Chat: Network Insights Episode 77Building Out the Nimble Portfolio by Scaling with Intel Platform – Conversations in…